Close Menu

BOSTON (GenomeWeb Daily News) – While panelists at a session at the American Society of Human Genetics annual meeting on Saturday said that the public is cautiously interested in including whole-exome or whole-genome sequencing as part of newborn screening efforts, there are concerns regarding privacy as well as the technologies' ability to meet the technical criteria required for such public health screening.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The head of Operation Warp Speed tells Bloomberg he expects the paused AstraZeneca and Johnson & Johnson vaccine trials to resume soon.

A new UK government says socioeconomic factors, not genetics, account for disparities in deaths due to COVID-19 between ethnic groups, the Financial Times reports.

NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.

In Nature this week: CRISPR-Cas3 system for making large deletions efficiently, more.

Nov
24
Sponsored by
Illumina

Numerous companies now offer non-invasive prenatal screening (testing), many on different technology platforms.